Ganymede

About Ganymede

Ganymede is a low-code platform that integrates lab instruments, ELN/LIMS, and data infrastructure into a single FAIR data cloud, automating data flow and analysis for biotech applications. This solution reduces manual data tasks by at least 20%, enabling scientists to focus on research rather than data management.

```xml <problem> In biotech and pharmaceutical labs, scientific data is often trapped within disparate instruments, electronic lab notebooks (ELNs), and laboratory information management systems (LIMS), leading to data silos and manual data handling. This fragmented data landscape hinders automation, increases the risk of errors, and prevents scientists from fully leveraging their data for analysis and AI applications. </problem> <solution> Ganymede provides a low-code platform that unifies lab instruments, ELN/LIMS, and data infrastructure into a single FAIR (Findable, Accessible, Interoperable, and Reusable) data cloud. The platform automates data flow, standardizes data formats, and ensures data integrity, saving scientists time and enabling them to focus on research. By connecting every instrument and automating analysis, Ganymede eliminates tedious data tasks, reduces data entry errors, and provides a foundation for AI-driven insights. The platform's modular design allows for flexible integration with existing lab systems and supports a wide range of scientific workflows, from small molecules to cell and gene therapies. </solution> <features> - Connectors for a wide range of lab instruments, ELNs, and LIMS, with tools to build new connectors as needed - Automated data capture and parsing into structured, FAIR-compliant tables - Flow-based web IDE for writing Lab-as-Code automation and building pipelines - Version control with Git and an append-only data model for data integrity - Business intelligence (BI) tools for data visualization and analysis - Ability to virtualize scientific analysis applications within the platform's UI - Compliant data storage with context, traceability, and versioning </features> <target_audience> Ganymede targets biotech and pharmaceutical companies, including scientists, lab managers, IT professionals, and R&D leaders, who seek to streamline their lab operations, improve data quality, and accelerate drug discovery. </target_audience> <revenue_model> Ganymede offers a modular platform with tiered pricing based on the number of instruments connected, data volume, and level of support required. </revenue_model> ```

What does Ganymede do?

Ganymede is a low-code platform that integrates lab instruments, ELN/LIMS, and data infrastructure into a single FAIR data cloud, automating data flow and analysis for biotech applications. This solution reduces manual data tasks by at least 20%, enabling scientists to focus on research rather than data management.

Where is Ganymede located?

Ganymede is based in Palo Alto, United States.

When was Ganymede founded?

Ganymede was founded in 2022.

How much funding has Ganymede raised?

Ganymede has raised 15200000.

Location
Palo Alto, United States
Founded
2022
Funding
15200000
Employees
54 employees
Major Investors
Caffeinated Capital
Looking for specific startups?
Try our free semantic startup search

Ganymede

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Ganymede is a low-code platform that integrates lab instruments, ELN/LIMS, and data infrastructure into a single FAIR data cloud, automating data flow and analysis for biotech applications. This solution reduces manual data tasks by at least 20%, enabling scientists to focus on research rather than data management.

ganymede.bio7K+
cb
Crunchbase
Founded 2022Palo Alto, United States

Funding

$

Estimated Funding

$15.2M+

Major Investors

Caffeinated Capital

Team (50+)

No team information available. Click "Fetch founders" to run a focused founder search.

Company Description

Problem

In biotech and pharmaceutical labs, scientific data is often trapped within disparate instruments, electronic lab notebooks (ELNs), and laboratory information management systems (LIMS), leading to data silos and manual data handling. This fragmented data landscape hinders automation, increases the risk of errors, and prevents scientists from fully leveraging their data for analysis and AI applications.

Solution

Ganymede provides a low-code platform that unifies lab instruments, ELN/LIMS, and data infrastructure into a single FAIR (Findable, Accessible, Interoperable, and Reusable) data cloud. The platform automates data flow, standardizes data formats, and ensures data integrity, saving scientists time and enabling them to focus on research. By connecting every instrument and automating analysis, Ganymede eliminates tedious data tasks, reduces data entry errors, and provides a foundation for AI-driven insights. The platform's modular design allows for flexible integration with existing lab systems and supports a wide range of scientific workflows, from small molecules to cell and gene therapies.

Features

Connectors for a wide range of lab instruments, ELNs, and LIMS, with tools to build new connectors as needed

Automated data capture and parsing into structured, FAIR-compliant tables

Flow-based web IDE for writing Lab-as-Code automation and building pipelines

Version control with Git and an append-only data model for data integrity

Business intelligence (BI) tools for data visualization and analysis

Ability to virtualize scientific analysis applications within the platform's UI

Compliant data storage with context, traceability, and versioning

Target Audience

Ganymede targets biotech and pharmaceutical companies, including scientists, lab managers, IT professionals, and R&D leaders, who seek to streamline their lab operations, improve data quality, and accelerate drug discovery.

Revenue Model

Ganymede offers a modular platform with tiered pricing based on the number of instruments connected, data volume, and level of support required.

Ganymede - Funding: $15M+ | StartupSeeker